EBITDA growth and maintaining ROE above 10%
First written in FY2017. 12 of 23 entries say "Restated". Latest entry: FY2026.
0 other companies' latest entry also says "Other".
- FY2026FY2026 outlook and current-year results disclosedAnnual report
「The consolidated EBITDA margin for the current consolidated fiscal year was 14.0%, up 0.2 percentage points from the previous fiscal year. FY2026 is the second year of the 18th Medium-Term Management Plan, and the company projects a consolidated EBITDA margin of 15.1% and adjusted ROE of 12.7%.」
While restating the targets of the 18th Medium-Term Management Plan, the company disclosed the current-year EBITDA margin of 14.0%, adjusted ROE of 12.6%, and FY2026 outlook of 15.1% and 12.7%, respectively. - FY2026-H1RestatedAnnual report
「For FY2027, the final year of the 18th Medium-Term Management Plan, the company has set targets of consolidated sales of ¥700 billion, an EBITDA margin of 17% and adjusted ROE of 15%.」
The company reconfirmed the FY2027 targets of the 18th Medium-Term Management Plan for enhancing corporate value. - FY2025RaisedAnnual report
「Based on this approach, the targets for the final year of the 18th Medium-Term Management Plan are net sales of ¥700 billion, an EBITDA margin of 17% and adjusted ROE of 15%.」
The company updated the target framework from the 17th Medium-Term Management Plan's sales of ¥610 billion, EBITDA of ¥89.0 billion and ROE of 13% to the 18th plan's sales of ¥700 billion, EBITDA margin of 17% and adjusted ROE of 15%. - FY2025-H1RestatedAnnual report
「The Group aims to enhance corporate value while achieving both growth and profitability. As targets for FY2024, the final year of the 17th Medium-Term Management Plan, it has set consolidated net sales of ¥610 billion, EBITDA of ¥89 billion and adjusted ROE of more than 13%.」
The company reconfirmed the final-year targets of the 17th Medium-Term Management Plan: sales of ¥610 billion, EBITDA of ¥89.0 billion and adjusted ROE above 13%. - FY2024RaisedAnnual report
「Based on the above approach, the company has currently set final-year targets for the 17th Medium-Term Management Plan of sales of ¥610 billion, EBITDA of ¥89.0 billion and adjusted ROE of 13%.」
The final-year targets of the 17th Medium-Term Management Plan were updated to sales of ¥610 billion, EBITDA of ¥89.0 billion and adjusted ROE of 13%. FY2023 results were consolidated EBITDA of ¥82.188 billion and adjusted ROE of 12.9%. - FY2024-Q3ReframedAnnual report
「For the final year of the 17th Medium-Term Management Plan, the company has set targets of consolidated sales of ¥550 billion, consolidated EBITDA of ¥85.0 billion and adjusted ROE above 13%.」
The company changed the previous target of a 17% consolidated EBITDA margin to consolidated EBITDA of ¥85.0 billion and raised the consolidated sales target to ¥550 billion. The target of adjusted ROE above 13% was maintained. - FY2024-Q2RestatedAnnual report
「As targets for FY2024, the final year of the 17th Medium-Term Management Plan, we have set consolidated net sales of ¥500 billion, a consolidated EBITDA margin of 17% and adjusted ROE of more than 13%.」
The company reconfirmed the FY2024 numerical targets, including an EBITDA margin of 17% and adjusted ROE above 13%. - FY2024-Q1RestatedAnnual report
「As targets for FY2024, the final year of the 17th Medium-Term Management Plan, we have set consolidated net sales of ¥500 billion, a consolidated EBITDA margin of 17% and adjusted ROE of more than 13%.」
The company reconfirmed the FY2024 numerical targets for enhancing corporate value: a consolidated EBITDA margin of 17% and adjusted ROE above 13%. - FY2023Full-year results and the following year's outlook disclosedAnnual report
「The consolidated EBITDA margin for the current consolidated fiscal year was 11.3%, down 1.5 percentage points from the previous fiscal year, and adjusted ROE was 9.6%, down 0.4 percentage points. For FY2023, the company projects a consolidated EBITDA margin of 12.2% and adjusted ROE of 18.5%.」
While restating the targets of the 17th Medium-Term Management Plan, the company disclosed current-year results and its FY2023 outlook. Current-year results for the EBITDA margin and adjusted ROE declined from the previous fiscal year and were below the FY2024 targets. - FY2023-Q3RestatedAnnual report
「As targets for FY2024, the final year of the 17th Medium-Term Management Plan, we have set consolidated net sales of ¥500 billion, a consolidated EBITDA margin of 17% and adjusted ROE of more than 13%.」
The company restated the numerical targets for FY2024 under the 17th Medium-Term Management Plan. - FY2023-Q2RestatedAnnual report
「As targets for FY2024, the final year of the 17th Medium-Term Management Plan, we have set consolidated net sales of ¥500 billion, a consolidated EBITDA margin of 17% and adjusted ROE of more than 13%.」
The company restated the FY2024 targets under the 17th Medium-Term Management Plan of an EBITDA margin of 17% and adjusted ROE above 13%. - FY2023-Q1ReframedAnnual report
「As targets for FY2024, the final year of the 17th Medium-Term Management Plan, we have set consolidated net sales of ¥500 billion, a consolidated EBITDA margin of 17% and adjusted ROE of more than 13%.」
The company changed the previous FY2025 targets of an EBITDA margin above 18% and adjusted ROE above 13% to targets for FY2024 under the 17th Medium-Term Management Plan of an EBITDA margin of 17% and adjusted ROE above 13%. - FY2021RaisedAnnual report
「As numerical targets for our growth strategy, we have set an EBITDA margin of more than 18% and adjusted ROE of more than 13% for FY2025, and aim to become a company capable of achieving these targets sustainably.」
In addition to the previous ongoing target of maintaining ROE above 10%, the company set higher numerical targets of an EBITDA margin above 18% and adjusted ROE above 13% for FY2025. - FY2021-Q2RestatedAnnual report
「The Group aims to enhance corporate value while achieving both growth and profitability. As key management indicators, in addition to expanding EBITDA, we continuously target an ROE of more than 10%.」
The company restated expansion of EBITDA and maintaining ROE above 10% as management indicators. - FY2021-Q1RestatedAnnual report
「The Group aims to enhance corporate value while achieving both growth and profitability. As key management indicators, in addition to expanding EBITDA, we continuously target an ROE of more than 10%.」
The company restated expansion of EBITDA and maintaining ROE above 10% as management indicators. - FY2020AdvancedAnnual report
「Metric Current consolidated fiscal year (actual) FY2021 target Consolidated sales (¥ million) 406,886 490,000 Consolidated EBITDA margin (%) 13.5% 15.5% Adjusted ROE (%) 8.7% Above 10% Three-year cumulative operating cash flow (¥ million) 40,324 140,000」
Full-year results against the FY2021 targets were disclosed, quantifying progress toward the targets, including an EBITDA margin of 13.5% and adjusted ROE of 8.7%. - FY2020-Q3RestatedAnnual report
「The Group aims to enhance corporate value while achieving both growth and profitability. As key management indicators, in addition to expanding EBITDA, we continuously target an ROE of more than 10%.」
The company restated expansion of EBITDA and maintaining ROE above 10% as management indicators. - FY2020-Q1RestatedAnnual report
「The Group aims to enhance corporate value while achieving both growth and profitability. As key management indicators, in addition to expanding EBITDA, we continuously target an ROE of more than 10%.」
The company restated expansion of EBITDA and maintaining ROE above 10% as management indicators. - FY2019WorsenedAnnual report
「For the current consolidated fiscal year, EBITDA was ¥54.0 billion, down 1.8% year on year, ROE was 6.4%, down 0.3 percentage points, and adjusted ROE excluding the effect of goodwill amortization was 8.2%, down 1.3 percentage points.」
EBITDA, ROE and adjusted ROE all declined from the previous fiscal year, falling short of the target of ROE above 10%. - FY2019-Q2RestatedAnnual report
「The Group aims to enhance corporate value while achieving both growth and profitability. As key management indicators, in addition to expanding EBITDA, we continuously target an ROE of more than 10%.」
The company restated expansion of EBITDA and maintaining ROE above 10% as ongoing management targets. - FY2019-Q1RestatedAnnual report
「The Group aims to enhance corporate value while achieving both growth and profitability. As key management indicators, in addition to expanding EBITDA, we continuously target an ROE of more than 10%.」
The company restated expansion of EBITDA and maintaining ROE above 10% as ongoing management targets. - FY2018AdvancedAnnual report
「As key management indicators, the company aims to expand EBITDA while maintaining ROE consistently above 10%.」
The targets were restated, and full-year results of EBITDA of ¥56.4 billion, ROE of 6.7% and adjusted ROE of 9.5% were disclosed. EBITDA increased 6.3% year on year, but ROE remained below 10%. - FY2017First statedAnnual report
「As key management indicators, the company aims to expand EBITDA while maintaining ROE consistently above 10%.」
The company explicitly stated for the first time that expansion of EBITDA and maintaining ROE above 10% are ongoing management targets.